Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies

被引：0
|
作者：
T. Sakakida
T. Ishikawa
Y. Chihara
S. Harita
J. Uchino
Y. Tabuchi
S. Komori
J. Asai
T. Narukawa
A. Arai
H. Tsunezuka
T. Kosuga
H. Konishi
M. Moriguchi
H. Yasuda
F. Hongo
M. Inoue
S. Hirano
O. Ukimura
Y. Itoh
T. Taguchi
K. Takayama
机构：
[1] Kyoto Prefectural University of Medicine,Department of Gastroenterology and Hepatology, Graduate School of Medical Science
[2] Kyoto Prefectural University of Medicine,Outpatient Oncology Unit, University Hospital
[3] Kyoto Prefectural University of Medicine,Department of Pulmonary Medicine, Graduate School of Medical Science
[4] Kyoto Prefectural University of Medicine,Department of Dermatology, Graduate School of Medical Science
[5] Kyoto Prefectural University of Medicine,Department of Urology, Graduate School of Medical Science
[6] Kyoto Prefectural University of Medicine,Department of Otolaryngology
[7] Kyoto Prefectural University of Medicine,Head and Neck Surgery, Graduate School of Medical Science
[8] Kyoto Prefectural University of Medicine,Division of Thoracic Surgery, Department of Surgery, Graduate School of Medical Science
[9] Kyoto Prefectural University of Medicine,Division of Digestive Surgery, Department of Surgery, Graduate School of Medical Science
[10] Kyoto Prefectural University of Medicine,Division of Endocrine and Breast Surgery, Department of Surgery, Graduate School of Medical Science
来源：
Clinical and Translational Oncology | 2020年 / 22卷
关键词：
Immune-related adverse events; Programmed cell death 1 blockade; Immune checkpoint inhibitors; Antinuclear antibodies; Autoimmune diseases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：919 / 927
页数：8
相关论文
共 50 条
  • [31] Molecular interactions of antibodies with PD-1/PD-L1 proteins
    Vasilakaki, Sofia
    Vathiotis, Ioannis
    Panagiotou, Emmanouil
    Dimakakos, Evangelos
    Gomatou, Georgia
    Kotteas, Elias
    IMMUNOTHERAPY, 2024, 16 (01) : 21 - 28
  • [32] Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer
    Chen, Miaomiao
    Zhou, Yuli
    Bao, Kaicheng
    Chen, Siyu
    Song, Guoqing
    Wang, Siliang
    BIODRUGS, 2025,
  • [33] PD-L1 blockade efficacy relies on host cell PD-L1
    Brownell, I.
    Udey, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : 1000 - 1000
  • [34] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    B Paiva
    A Azpilikueta
    N Puig
    E M Ocio
    R Sharma
    B O Oyajobi
    S Labiano
    L San-Segundo
    A Rodriguez
    I Aires-Mejia
    I Rodriguez
    F Escalante
    A G de Coca
    A Barez
    J F San Miguel
    I Melero
    Leukemia, 2015, 29 : 2110 - 2113
  • [35] PD-1/PD-L1 Blockade Enhances the Efficacy of Imatinib in Gastrointestinal Stromal Tumor (GIST)
    Seifert, Adrian M.
    Kim, Teresa S.
    Greer, Jonathan B.
    Cohen, Noah A.
    Beckman, Michael J.
    Santamaria-Barria, Juan A.
    Zeng, Shan
    Crawley, Megan H.
    Green, Benjamin L.
    DeMatteo, Ronald P.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2014, 219 (03) : S129 - S129
  • [36] Cimetidine enhances PD-1 blockade efficacy in melanoma by regulating PD-L1 expression on tumor
    Lee, B.
    Kim, D.
    Lee, B.
    Lee, J.
    Shin, K.
    Kim, H.
    Ko, H.
    Kim, B.
    Kim, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S217 - S217
  • [37] PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma
    Paiva, B.
    Azpilikueta, A.
    Puig, N.
    Ocio, E. M.
    Sharma, R.
    Oyajobi, B. O.
    Labiano, S.
    San-Segundo, L.
    Rodriguez, A.
    Aires-Mejia, I.
    Rodriguez, I.
    Escalante, F.
    de Coca, A. G.
    Barez, A.
    San Miguel, J. F.
    Melero, I.
    LEUKEMIA, 2015, 29 (10) : 2110 - 2113
  • [38] Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade
    Lee, Bo Ryeong
    Chae, Sehyun
    Moon, Jihyun
    Kim, Myeong Joon
    Lee, Hankyu
    Ko, Hyuk Wan
    Cho, Byoung Chul
    Shim, Hyo Sup
    Hwang, Daehee
    Kim, Hye Ryun
    Ha, Sang-Jun
    JCI INSIGHT, 2020, 5 (14)
  • [39] New strategies with PD-1/PD-L1 blockade in lung cancer
    不详
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (SUPPL 3) : 54 - 58
  • [40] PD-L1/PD-1 blockade in breast cancer: The immunotherapy era
    Li, Chia-Jung
    Lin, Li-Te
    Hou, Ming-Feng
    Chu, Pei-Yi
    ONCOLOGY REPORTS, 2021, 45 (01) : 5 - 12
12345